Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Afrocentric InvestmentJSE:ACT -6.49%53 Days Sales Outstanding is 30.00 as of Dec. 2025, which is 35% above its 10-year median of 22.15. GuruFocus rates JSE:ACT with a GF Score™ of 53/100 and a GF Value™ of R2.02 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 662 Healthcare Providers & Services companies, Afrocentric Investment ranks better than 76.28% on this metric.
The historical rank and industry rank for Afrocentric Investment's Days Sales Outstanding or its related term are showing as below:
JSE:ACT'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 18.1 Med: 22.15 Max: 50.41
Current: 24.5
During the past 13 years, Afrocentric Investment's highest Days Sales Outstanding was 50.41. The lowest was 18.10. And the median was 22.15.
JSE:ACT's Days Sales Outstanding is ranked better than 76.28% of 662
companies
in the Healthcare Providers & Services industry
Industry Median: 45.825
vs JSE:ACT: 24.50
Afrocentric Investment's Days Sales Outstanding
increased
from Dec. 2024 (19.32) to Dec. 2025 (30.00).
Afrocentric Investment (JSE:ACT) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Afrocentric Investment Days Sales Outstanding Related Terms
Afrocentric Investment Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Afrocentric Investment's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Afrocentric Investment Days Sales Outstanding Chart
JSE:ACT vs HCA, THC, DVA: Days Sales Outstanding Comparison
For the Medical Care Facilities subindustry, Afrocentric Investment's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Afrocentric Investment Days Sales Outstanding vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Afrocentric Investment's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Afrocentric Investment's Days Sales Outstanding falls into.
Afrocentric Investment Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Afrocentric Investment (JSE:ACT) has a Days Sales Outstanding of 30.00 as of Dec. 2025. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Afrocentric Investment and its competitors. This is 35% above median its historical median of 22.15. Over the past decade, Afrocentric Investment's Days Sales Outstanding has ranged from 18.10 to 50.41. According to the industry distribution chart, Afrocentric Investment ranks #157 out of 662 companies in the Healthcare Providers & Services industry, placing it in the top 23.7%.
Is Afrocentric Investment's Days Sales Outstanding too high?
Afrocentric Investment's current Days Sales Outstanding of 30.00 is 35% above median its 10-year median of 22.15. Over the past 10 years, this metric has ranged from a low of 18.10 to a high of 50.41. The Healthcare Providers & Services industry median Days Sales Outstanding is 45.83. Afrocentric Investment's value of 30.00 is 34.5% below this industry median. Based on the distribution chart, Afrocentric Investment ranks #157 out of 662 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Afrocentric Investment has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Afrocentric Investment's Days Sales Outstanding compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Afrocentric Investment ranks #157 out of 662 companies for Days Sales Outstanding. This places Afrocentric Investment in the top 24% of its industry — outperforming the majority of peers. The industry median Days Sales Outstanding is 45.83. Afrocentric Investment's value of 30.00 is 34.5% below this benchmark. Historically, Afrocentric Investment's own Days Sales Outstanding has ranged from 18.10 to 50.41 over the past decade. While the company's 10-year median is 22.15 vs. the industry median of 45.83, Afrocentric Investment has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Healthcare Providers & Services company?
The median Days Sales Outstanding among Healthcare Providers & Services companies is 45.83, based on 662 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Afrocentric Investment's current Days Sales Outstanding of 30.00 is 34.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Afrocentric Investment and its competitors. For the Healthcare Providers & Services industry, the median Days Sales Outstanding is 45.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Afrocentric Investment's current Days Sales Outstanding is 30.00, which is 35% above median its own 10-year median of 22.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Afrocentric Investment stock overvalued right now?
Based on GuruFocus' analysis, Afrocentric Investment (JSE:ACT) is currently considered Possible Value Trap. The stock's GF Value™ is R2.02, compared to a current price of R0.72 — trading 64.4% below its estimated fair value. The current Days Sales Outstanding is 30.00, which is 35% above median its 10-year median of 22.15 and 34.5% below the Healthcare Providers & Services industry median of 45.83. Afrocentric Investment's overall GF Score™ is 53/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Afrocentric Investment (JSE:ACT), the current Days Sales Outstanding is 30.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Afrocentric Investment (JSE:ACT) Overvalued in 2026?
Based on GuruFocus' analysis, Afrocentric Investment stock appears to be undervalued.
The current stock price of R0.72 is trading 64.4% below its estimated GF Value™ of R2.02.
GuruFocus considers Afrocentric Investment to be Possible Value Trap.
Key valuation signals for JSE:ACT:
Days Sales Outstanding: 30.00 (35% above median its 10-year median of 22.15)
GF Value™: R2.02 vs. price of R0.72 (64.4% below fair value)
Industry Position: 34.5% below the Healthcare Providers & Services median (#157 of 662)
No single metric tells the full story. See the JSE:ACT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Afrocentric Investment Corp Ltd is an investment holding company providing specialised services and products to the public and private healthcare sectors. It focuses on making quality healthcare accessible and affordable to members and beneficiaries, with the principal objective of ensuring the delivery of efficient health management services and the distribution of quality products. Its business segments include Healthcare SA, comprising medical scheme administration and health risk management services; Healthcare Retail, comprising pharmaceutical sales and services; Healthcare Africa, comprising healthcare services outside South Africa in Namibia and Mauritius; and IT-related services predominantly within South Africa. It operates across South Africa, Botswana, Mauritius, and Namibia.
53GF Score
Get the complete analysis for JSE:ACT
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:ACT has been successfully added to your 
